Scientists found that MSCs confer breast cancer resistance to doxorubicin by diminishing its intratumoral accumulation. Hyaluronan, a major extracellular matrix product of MSCs, was found to mediate the chemoresistant effect.
[Oncogene]
Home Newsletters Mesenchymal Cell News Mesenchymal Stromal Cells Confer Breast Cancer Doxorubicin Resistance by Producing Hyaluronan
